Although we have previously observed that snRNP alterations are associated with deficits in RNA splicing in AD brain [24, 32]—a finding recently confirmed by others [52]—the fact that there was little overlap with RNA binding proteins at the network level suggests that abundance levels of RNA binding proteins do not correlate directly with levels of alternative splicing. The gene discussed is LSM2; the disease is Alzheimer disease.